COMPANY
Clinical Phase 3
Location: Libertyville, IL · source · Oct 15, 2026
Profile checked Oct 10, 2026
Keywords: Migraine Headache Chronic Migraine Marcaine
Timeline
- Trial start Phase 3: Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine source ↗
- Trial start Phase 4: Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT03337620 | Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine | Phase 3 | Completed | Sep 20, 2017 | Nov 15, 2023 (actual) |
| NCT01709708 | Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine | Phase 4 | Completed | 2012-09 | 2014-02 (actual) |
